Cerebrospinal Fluid
18
3
4
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.6%
1 terminated out of 18 trials
83.3%
-3.2% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (18)
Molecular Insights Into Post-Cardiac Arrest Brain Injury Via CSF Multi-Omics
Dynamic Measurement of Cerebrospinal Fluid in Healthy Subjects: Pilot Study
Stenting Versus Neurosurgical Treatment of Idiopathic Intracranial Hypertension.
Analysis of Cerebrospinal Fluid in Patients With Cerebral Toxoplasmosis at CHSD (2004-2024)
Analysis of Disturbances in Neurofluid Dynamics in Type I Chiari Malformations
Xanamem™ in Healthy Elderly Subjects
Assessment of Cerebrospinal Fluid Flow Related Disorders Using a Phase-contrast Magnetic Resonance Imaging Technique.
Comparison of Different CSF Sampling Sites on External Ventricular Drains
Impact of Cerebral Ventricular Dilatations and Cerebrospinal Fluid Pulsations on Periventricular White Matter in Hydrocephalic Patients
Cerebrospinal Fluid Gravity Correlation Analysis
Does N-Acetylcysteine Decrease Spontaneous Oxidation of Central Neural Dopamine in Parkinson's Disease?
Transcriptome Sequencing Analysis of Whole Blood From Patients With Trigeminal Neuralgia
Ceftobiprole's Cerebrospinal Fluid Penetration in Patients With External Ventricular Derivation (CEFTO-EVD)
A Study on Central Transport Characteristics of Flurbiprofen Axetil in Elderly Patients
Cerebrospinal Acid-base in Pregnant and Non-pregnant Fertile Women
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
Compassionate Use of Ceftriaxone in Patients With Amyotrophic Lateral Sclerosis (ALS)
Cerebrospinal Fluid Repository